VinaykumarK.PuduvalliMD

Clinical Trials

• Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) Start of enrollment: 2007 Nov 28

  Active, not recruiting

  Phase 1, Phase 2

• Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I Start of enrollment: 2008 Apr 29

  Terminated

  Phase 1

• Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) Start of enrollment: 2011 Jun 01

  Terminated

  Phase 1, Phase 2

• Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma Start of enrollment: 2011 Jul 12

  Completed

  Phase 1, Phase 2

• A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2013 Jul 18

  Completed

  Phase 1, Phase 2

• DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors Start of enrollment: 2014 Sep 11

  Completed

  Phase 1

• A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma Start of enrollment: 2020 Jun 08

  Terminated

  Phase 1, Phase 2

  Roles: Principal Investigator, Contact

• Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma Start of enrollment: 2024 Jul 30

  Not yet recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Join now to see all